GGrantIndex
← Search

EVALUATION OF THE IMMUNOLOGIC IMPACT OF RAF INHIBITORS TO GUIDE OPTIMAL COMBINATION OF RAF INHIBITORS AND IMMUNOTHERAPY FOR THE TREATMENT

$322,849FY2012Department of DefenseDOD

Sloan-Kettering Institute For Cancer Research

Investigators

View source on USAspending →
EVALUATION OF THE IMMUNOLOGIC IMPACT OF RAF INHIBITORS TO GUIDE OPTIMAL COMBINATION OF RAF INHIBITORS AND IMMUNOTHERAPY FOR THE TREATMENT · GrantIndex